FDA OKs re­turn of Pri­matene

Boston Herald - - BIZ SMART -

A new ver­sion of the once-pop­u­lar asthma in­haler Pri­matene Mist will soon re­turn to U.S. stores. The Food and Drug Ad­min­is­tra­tion ap­proved the over-the-counter aerosol in­haler late Wed­nes­day. It’s for tem­po­rary re­lief of mild, in­ter­mit­tent asthma symp­toms in peo­ple ages 12 and up. The orig­i­nal Pri­matene Mist was pulled from store shelves seven years ago be­cause the in­haler’s ozone-de­plet­ing pro­pel­lant had been banned. That ver­sion had been mar­keted for half a cen­tury, in­clud­ing in mem­o­rable TV ads. The new prod­uct from Am­phastar Phar­ma­ceu­ti­cals uses a safer pro­pel­lant. The in­haler will cost about $25 and should be avail­able by the end of the year.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.